Europe

In 2022 alone, Moldova received nearly a billion euros in foreign aid, with 80% of this amount comprising loans. While this is attributed to the economic policies of the current leaders, former Prime Minister Ion Chicu argues that

The UK GDP growth forecast has been lowered in 2024 to 0.7% from the previous 1.8%. This was announced by the head of the Ministry of Finance of the United Kingdom, Jeremy Hunt, speaking in the House of Commons with the autumn budget message.

The share of agriculture in the Serbian economy is gradually decreasing due to the active development of the service sector and industry.

The stereotype that "an artist should be hungry" is irrelevant in the 21st century. In modern market relations, art and its representatives cannot survive if they do not earn money.

According to the latest production cost and producer price calculations in the organic sector, producers in Germany received an average 60.36 cents/kg of organic milk in the accounting year 2022/23, as follows from the press release of the European Milk Board.

In 2018-2022, the production of chocolate confectionery in Serbia gradually decreased: in 2022, 20.5 thousand tons of chocolate were produced in the country, which is 7.2% less than in 2021.

Serbia has been developing dynamically since the beginning of the XXI century. Despite the disruption of logistics chains, as well as the consequences of international economic sanctions, trade liberalization, restructuring and privatization of some enterprises

According to the quarterly update of the cost study established by the Farm Economics and Rural Studies Office (BAL), milk production costs in Germany amount to 49.73 cents per kg (as of July 2023). With 46.87 cents per kg, costs were at a lower level in April 2023.

According to the quarterly update of the cost study established by the Farm Economics and Rural Studies Office (BAL), milk production costs in Germany amount to 46.68 cents per kg (as of April 2023).

During 2022, Switzerland’s biotech industry again showed its resilience by adjusting to geopolitical disruptions while continuing to play a key role in driving global healthcare innovation. The Swiss biotech companies overall recorded revenues of CHF 6.8 billion.